Category: Federal Forum Posters
Purpose: In 2017, an Indian Health Service (IHS) initiative challenged pharmacists to expand their role in patient care by transitioning from single-disease state clinics to a comprehensive, multi-disease state clinical approach. In a setting in which primary care providers, physical space, and access to care are limited, pharmacists may be utilized as first-line providers to provide patient-specific benefit and financial resources. The objective of this study is to evaluate the benefit of diversifying clinical pharmacy services to improve patient outcomes such as access to care, quality of care standards, and revenue in an outpatient ambulatory care clinic
Methods: The study is pending approval with the Indian Health Service Internal Review Board. A site-specific gap analysis will verify the need of specific services to be implemented by pharmacists while aligning with the National Clinical Pharmacy Specialist (NCPS) guidelines. This will provide baseline data as to the pharmacy’s current impact on clinical patient care. In accordance with American Accreditation for Ambulatory Health Care (AAAHC) standards of credentialing and privileging, pharmacists will work under collaborative practice agreements (CPA) and site-specific protocols to provide management and monitoring of anticoagulation, tobacco cessation, immunizations, hepatitis C, HIV Pre-Exposure Prophylaxis (PrEP), and Medication Therapy Management (MTM). Utilizing MTM billing codes and third party MTM services such as OutcomesMTM and Mirixa, claims will be tracked in terms financial revenue and time. Current pharmacy services of anticoagulation and tobacco cessation occurring in “silo clinics” on different days with different privileged pharmacists will transition to a multi-disease state clinic to manage one or multiple chief complaints in one visit. Outcomes to assess the impact of expanded services include total patient contact time, quantification of interventions, revenue in dollars, and compliance with national Government Performance and Results Act (GPRA) quality care measures.
Joseph Nardolillo– Student Pharmacist, PhusionRx, Coventry, RI